The Department of Defense (DoD) in conjunction with Humetrix, JAIC, and Project Salus, has released new data showing that Covid-19 “vaccines” are hardly the miracle that they are hailed as being; they do not work to protect against disease.
Molnupiravir, Merck, is a COVID Tablet, FDA boss Scott Gottlieb approved as antiviral, only 48% reduction for hospitalization, N=775 patients in one trial; compared to Ivermectin N=47717 patients of 32 trials, with 58%, 86% and 66% improvement in hospitalization, prophylaxis and early treatments respectively, and 99.98% reduction in viral load. Elephant in the room ignored.